Maybe this is a “scientific first” for Sanford Burnham Presby Medical Discovery Institute but not for Nova Cells Institute of Mexico (NCIM) which introduced a stem cell homing compound it created back in 2015! Dubbed the “Beacon Factor” you can read about it here and in a July 2015 blog entry here.
NCIM introduced its stem cell homing “Beacon Factor” in 2015. Sanford Burnham Presby Medical Discovery Institute announced their stem cell homing creation this year, 2020. five years after NCIM. Five years. Better late than never comes to mind. This and “such hubris”….. to call SBPDI’s latecomer a “scientific first” , that is.
Nova Cells Institute of Mexico: the little guys who have made progress on a shoestring budget, egged on by an overwhelming desire to revolutionize healthcare…..one (patient) turnaround at a time.
If you need help with questions or concerns about stem cell therapies, NCIM’s proprietary Beacon Factor, patient responses to treatment, or just about anything else then grab your phone or keyboard and contact NCIM.
The Covid-19 pandemic definitely impacted travel into and out of Mexico which kept many sick & ailing people from being able to get to NCIM’s hospital for treatment. This has begun to ease up as scientifically validated prevention & detection measures have become widely available (including over-the-counter ones) and MDs across the world have zeroed in on drugs & therapies that keep Covid-19 infected people from landing in ICU or worse. Once approved vaccines go into widespread use in the US, Canada, Mexico, in the EU and beyond, it is expected that international travel will loosen up even more.
What probably will not change quickly is the pandemic-fueled economic downturn in most nations. Many experts expected housing prices and some aspects of medical care to go down but it has not. In fact, In the US these have gone up. With so many people across the world paying more for…well….just about everything under the sun, NCIM has not only been able to maintain its pre-pandemic pricing structure but also to get generous patrons to help reduce the cost of treatment for some patients.
Those interested in learning more should email NCIM at NCInfodesk@gmail.com or call the NCIM US information desk at 1-562-916-3410.
Nova Cells Institute has never worked with embryonic or fetal stem cells, and never will. Embryonic and fetal stem cells can produce tumors (These are classified as pluripotent” which means they can form teratomas and other tumors in certain instances such as being injected into the central nervous system). The adult stem cells Nova Cells uses (umbilical cord, Wharton’s Jelly, placenta-derived, and a patient’s own bone marrow) are “multipotent” which limits the body cell types they can become (These stem cells do not form teratomas or such. Some private stem cell clinics in Europe and the US have injected adult stem cells into organs such as kidneys and eyes which caused problems and complications. Nova Cells Institute has never injected stem cells into an organ). Let’s be very clear about these points and a few others:
(1) Nova Cells was established in 2009. There are other companies that came along later on which use “Nova” in their company title, but these are NOT affiliated in any way with Nova Cells Institute of Mexico (NCIM).
(2) Nova Cells Institute has never used embryonic or fetal stem cells and never will (They can form tumors under certain circumstances).
(3) Nova Cells Institute only uses multipotent adult stem cells derived from umbilical cord blood, Wharton’s Jelly, placental tissue, and a patient’s own bone marrow.
(4) Nova Cells Institute administers stem cells by intravenous drip (On rare occasions Nova Cells affiliated doctors recommend an intrathecal or spinal tap infusion of cells. Everything related to this is spelled out, a process called “informed consent”. Patients who prefer not to do this are given cells by intravenous or IV drip).